cerebral mantle from the ventricle to the cortical surface; this appearance has been called the transmantle sign and the dysplasia has been labeled transmantle cortical dysplasia. First described in 1997 by Barkovich and colleagues, 2 this type of dysplasia spans the entire cerebral mantle and may represent a distinct type of malformation of cortical development under the broad category of cortical dysplasia. Some studies have found that the transmantle sign is associated with FCD Type II (cortical dysplasia due to abnormal neuronal migration), 16, 19 though it is unclear whether the transmantle sign is a unique feature of Type II dysplasias. Since its early description, relatively little has been elucidated concerning seizure-free outcomes in patients with the transmantle sign.
In this paper we report on 14 consecutive patients with FCD and the transmantle sign who underwent epilepsy surgery. We found that 12 of the 14 patients were seizure free after resection of the areas of MRI and electrophysiological abnormality. The 2 patients who failed to experience seizure freedom after surgery both underwent incomplete resection of the MRI areas of abnormality due to overlapping eloquent cortical areas. This retrospective study represents high favorable outcomes for epilepsy surgery in patients with the transmantle sign.
Methods

Study Population and Data Collection
Between February 1992 and October 2011, 14 patients with FCD and MRI findings of the transmantle sign underwent epilepsy surgery at the University of California, San Francisco. Data pertaining to patient demographics, seizure-related history, surgical details, neuroimaging, ECoG, pathology reports, and outcome were obtained from hospital and departmental records. All research protocols were approved by the University of California, San Francisco, institutional review board for human research.
Preoperative Evaluation
Preoperative data included date of seizure onset, type of seizure (simple partial, complex partial, and/or generalized), seizure frequency, seizure duration, medications, and other symptoms. Other preoperative tests included the Wada test, neuropsychological testing, EEG studies, MRI, and PET. Preoperative MRI was independently reviewed by experienced neuroradiologists (A.J.B. and A.E.D.). Imaging features included the extent of the abnormality (focal [≤ 3 cm], multigyral [> 3 cm], lobar, or hemispheric), the presence or absence of gray/white junction blurring, abnormal signal intensity of the cortex or underlying white matter, cortical thickening, gray matter heterotopia, abnormal cortical sulcation, and transmantle signs.
Resection of Epileptogenic Foci
Operative data were recorded, including the use of cortical and subcortical motor stimulation mapping, language and motor mapping, and ECoG. The goal of surgery was GTR of the area of abnormal electrocorticographic and/or MRI activity when possible. Gross-total resection of MRI abnormalities involved complete resection of the cortical areas with the transmantle sign, but not necessarily the subcortical white matter down to the ventricle. Subtotal resection was performed in patients with involvement of functionally eloquent brain areas as verified by intraoperative stimulation mapping. Extent of resection was designated as gross total or subtotal according to a review of preoperative and postoperative MR images and the preoperative and postoperative ECoG recordings. All cases used Stealth (Medtronic) or BrainLab frameless neuronavigation to assist with intraoperative localization.
Intraoperative ECoG was performed under general anesthesia, unless awake language mapping was necessary. Anesthetics were limited to nitrous oxide, narcotics, and dexmedetomidine. Recordings were obtained using a customized crown of 16 ball-tipped carbon electrodes referred to a common cerebral referenced electrode. When necessary, additional coverage for cortical surfaces not exposed by craniotomy was obtained by using subdural electrode strips. Sites generating epileptiform discharges or EEG patterns known to be associated with cortical dysplasia were marked with a paper ticket and photographed. The anatomical resection was tailored based on the extent of the ECoG abnormalities and the functional anatomy of each patient.
Resection of epileptogenic tissue determined by ECoG was based on criteria previously described. 6 A resection was considered complete if all tissue exhibiting critical patterns was resected, and tissue contiguous to these areas exhibiting potentially important patterns was included in the resection.
Five patients underwent implantation of chronic subdural electrode arrays for extraoperative seizure monitoring and electrical stimulation mapping when there was no clear localization of epileptic foci on EEG, and/or the lesion was adjacent to eloquent cortical areas. Extraoperative ECoG was used to guide resection and intraoperative ECoG was typically not repeated prior to resection.
Pathology Evaluation
Pathological specimens were obtained from central regions of MRI and ECoG abnormalities. Histological analysis on surgical margins was not performed. All pathological specimens were fixed for 12-24 hours in 10% buffered formalin, embedded in paraffin, and sectioned. Multiple sections were stained using H & E, Nissl stain, Bielschowsky stain, and glial fibrillary acidic protein. The pathological features of the specimens were all reviewed, including the presence of reactive astroglio sis, heterotopias, dyslamination, cytomegaly, dysmorphic neu rons, hypercellularity, balloon cells, bizarre cells, and mesial temporal sclerosis. All specimens were also classified according to the new ILAE classification system for FCD: 
Postoperative Outcome
Clinic visits and phone interviews were conducted for follow-up. Each patient's outcome was assessed using the ILAE seizure classification system: Class 1, seizure free and no auras; Class 2, only auras and no seizures; Class 3, 1-3 seizure days per year; Class 4, 4 seizure days per year or 50% reduction from baseline; Class 5, less than 50% reduction in seizure frequency from baseline, up to 100% increase from baseline; and Class 6, greater than 100% increase in seizure frequency. A comparison with FCD patients without the transmantle sign was made using a cohort of patients selected from the epilepsy surgery patient database at the University of California, San Francisco. 6 
Statistical Analysis
Contingency tables were created for FCD patients with and without the transmantle sign and seizure free versus residual seizure outcome. The chi-square test was used to calculate the p value for statistical significance. A probability value < 0.05 was considered statistically significant.
Results
Patient Characteristics
This study included 8 males and 6 female patients ranging in age from 7 months to 33 years, with a median age of 18.5 years. All patients experienced seizure onset during childhood, with median age of onset at 4.5 years of age and a range of 1 month to 12 years. Ten patients had complex partial seizures (including 3 with secondary generalized tonic-clonic seizures), 1 had simple partial seizures, and 6 suffered generalized tonic-clonic seizures. Six patients had associated developmental delay, and 1 patient displayed behavioral and cognitive regression (Table 1) .
Preoperative MRI Findings
Of the patients with transmantle sign, 10 patients had the lesion on the left hemisphere. Almost all of the lesions were located in the frontal and parietal lobes (9 in frontal, 4 parietal, and 1 occipital). All patients showed a transmantle sign, which is characterized as a region of T2/FLAIR signal abnormality that extends from the ventricle all the way to the cortical surface ( Figs. 1 and 2 ). At times, images needed to be acquired in oblique planes to identify the extent of the transmantle lesion. Often, the area of abnormal cortex is located at the bottom of a sulcus with a trail of signal abnormality extending to the ventricle, consistent with a transmantle sign. Three patients had bottom-of-sulcus dysplasia, which is a curvilinear hyperintense signal that extends for several millimeters along the gray-white junction at the bottom of a sulcus. 9 In addition, 7 patients had an appearance of cortical thickening on T1-weighted images (secondary to isointense signal abnormalities in the subcortical white matter), 1 patient had true cortical thickening (thick on FLAIR, T1-, and T2-weighted images), 5 had blurring of the gray-white junction, 2 had gray matter heterotopia, 1 had polymicrogyria, and 1 patient had hippocampal abnormalities (Table 1 ). The size of the lesion varied from focal (< 3 cm) to multigyral (> 3 cm, less than entire lobe). Five patients had focal lesions and 9 had multigyral lesions. All patients had a single FCD lesion with the transmantle sign.
Electroencephalography and ECoG Findings
All patients underwent video EEG monitoring prior to surgery and underwent intraoperative ECoG to localize epileptogenic foci ( Table 2 ). Five patients underwent intracranial EEG monitoring using subdural electrode grid placement. On EEG, 9 patients had abnormal interictal spikes or seizure activity lateralized to the left hemisphere, 4 had right lateralization, and 1 patient had bilateral abnormal waveforms arising from the frontal regions (later found to be localized to the left frontal lobe by ECoG). Intraoperative ECoG revealed epileptic foci in the frontal region (8 patients), parietal region (3 patients), frontal-temporal (2 patients), and occipital region (1 patient).
One important question is whether ECoG findings were limited to the MRI lesions or extended beyond them. Eleven patients had focal epileptogenic areas arising from the MRI lesion, and 3 patients had more diffuse abnormalities extending beyond the visible lesion. All patients had local epileptiform discharges and/or interictal spikes. In all cases, active areas on ECoG correlated with location of MRI lesions, with abnormal electrocorticographic activity arising from or containing the radiographic lesion. Twelve patients underwent complete resection of the MRI and ECoG abnormalities, whereas 1 patient had incomplete resection due to an overlapping epileptogenic zone with language areas, and 1 patient underwent multiple subpial transections due to the epileptogenic zone localizing to the motor and somatosensory cortices.
Histopathological Features
Thirteen surgical specimens were available for neuropathology review. Common features included cortical dyslamination (10/13), reactive gliosis (9/13), dysmorphic cells (9/13), hypercellularity (7/13), balloon cells (6/13), heterotopia (5/13), and cytomegaly (4/13; Fig. 3 , Table 3 ). Histological findings were graded according to the recent ILAE FCD Classification Scheme.
Postoperative Outcome
Postoperative seizure status was assessed at each follow-up time and categorized according to the ILAE outcome classification. The median length of follow-up was 4.5 years, ranging from 2 months to 16 years. Twelve patients (85.7%) were seizure free (ILAE Class 1), 1 patient (7.2%) showed slight improvement from baseline (ILAE Class 3), and 1 patient experienced worsened seizure frequency (ILAE Class 6) at last follow-up (Table 3) . Importantly, all patients (1-12) who underwent complete resection were completely seizure free, whereas 1 patient (Case 13) who received multiple subpial transections and vagus nerve stimulation and 1 patient (Case 14) who received STR of imaging and ECoG abnormalities had persistent seizures postoperatively. Case 12 underwent initial STR to preserve vision. However, he experienced continued seizures and therefore underwent a repeat operation with complete resection, after which he became seizure free.
To compare outcomes of resective surgery for FCD patients with transmantle sign to those without transmantle sign, we used an additional cohort of patients with FCD from our epilepsy database (Table 4) . 6 Excluding patients with transmantle sign, we found that 74 patients (64.9%) became seizure free after resective surgery, whereas 40 patients had residual seizures, after a median follow-up of 5.9 years (range 0.2-18.2 years). Of the 114 patients without transmantle sign, 79 (69%) underwent GTR of the imaging abnormality, and of those who received GTR, 65 (82%) became seizure free. Of the 13 patients with the transmantle sign who received resective epilepsy surgery, 12 (92.3%) became seizure free (all of whom received GTR). For those patients who underwent GTR, we found no statistically significant difference in seizure-free outcome between those with and those without the transmantle sign (c 2 = 0.8228, p = 0.3644; Table  4 ). However, patients with the transmantle sign were more likely to receive GTR compared with those without the transmantle sign, although this difference did not reach statistical significance (92% vs 69%; c 2 = 3.042, p = 0.08). Despite our small patient sample size, chi-square analysis revealed that patients who received surgery for FCD with the transmantle sign had significantly better seizure control after epilepsy surgery compared with those with without the transmantle sign (c 2 = 4.006; p = 0.0453; Table 4).
Discussion
The transmantle sign is an underrecognized phenomenon within the spectrum of FCDs, with distinct radiographic and prognostic features. It is defined by the radiological appearance of focal signal abnormality spanning the entire cortical mantle, and it is postulated to be a distinct type of FCD. 2, 3 In our study, we describe the clinical presentation, imaging, and postoperative course for 14 patients with the transmantle sign associated with pharmacoresistant epilepsy. All patients had concordant MRI and ECoG abnormalities. Patients who underwent complete resections (12/13 patients) became seizure free, and 1 patient who received multiple subpial transections and vagus nerve stimulation continued to have residual seizures.
From the data in our series, patients with the transmantle sign appear to share a similar profile with those with other malformations of cortical development, experiencing early seizure onset usually within the first decade of life and frequent daily seizures. Consistent with previous studies, seizure control is highly correlated with successful complete resection of the lesion on MRI and/ or ECoG. 6, 10, 11, [13] [14] [15] 17, 19 Unlike other cortical dysplasias, however, the highly localized extent of transmantle dysplasia has significant implications for management and prognosis. The transmantle sign on MRI may be subtle, but high resolution MRI with thin slices in different orientations can help to identify and define the extent of abnormality on imaging. Use of ECoG is essential for de- fining the functional electrocorticographic abnormalities. In all 14 patients, areas of epileptiform abnormality were well circumscribed and correlated with the MRI lesion, but in 3 patients, the ECoG findings extended beyond the imaging findings. Our data suggest that complete resection of both MRI and ECoG abnormalities offers a more favorable outcome. Compared with other FCDs without the transmantle sign, we found that the presence of the transmantle sign is highly prognostic toward seizurefree outcome. Even though a comparison of patients who received GTR did not show a significant difference between groups with and without the transmantle sign, patients with the transmantle sign are probably more likely to receive GTR due to the highly localized nature of the lesion. Chronic intracranial ECoG is not usually required to define the abnormal tissue but may be required for surgical planning where the abnormality is adjacent to eloquent cortical areas. Because of excellent prognosis of the transmantle sign for seizure control, careful preoperative imaging workup and surgical planning based on intraoperative neuronavigation and ECoG is used to guide every resective surgery for FCD with the transmantle sign in our practice.
With regards to histopathology, patients showed either FCD Type I (abnormal cortical lamination) or II (dysmorphic neurons with/without balloon cells). Based on the most recent Barkovich classification, which categorizes dysplasia based on imaging and histopathology, the patients with FCD Type II belong to Class I (abnor- mal neuronal and glial proliferation or apoptosis 3 ), or more specifically, transmantle cortical dysplasia corresponds to subclass I.C.2.d, whereas patients with FCD Type I belong to subclass III.C.2.
1 A previous report on 143 patients with malformations of cortical development showed that Barkovich Class I is correlated with favorable postoperative outcomes. 6 In our study, we did not find any unique histological features in the transmantle sign that differentiates it from other types of FCDs. However, the retrospective pathology analysis performed on older surgical specimens was limited and FCDs may be subject to sampling error depending on where the specimens were taken; therefore, future efforts will be aimed at careful surgical en bloc excision of dysplastic tissue to facilitate detailed architectural and cellular studies.
The origin of cortical dysplasia with the transmantle sign is unclear, but the imaging and histological information is highly suggestive of locally affected developmental processes. During development, the cortical progenitor radial glia undergo symmetrical and asymmetrical division to give rise to intermediate progenitors and immature neurons. 18 The intermediate progenitors undergo additional divisions to expand the population of immature neurons, which will migrate along the radial scaffold to the cortical surface. 18, 20 The transmantle sign noted on MRI spans from the ventricular surface, where the progenitors reside during development, to the cortex, where the neurons are located. This feature, along with the histopathological findings of subcortical neurons and dysmorphic neurons, strongly suggests that FCD with the transmantle sign arises from dysfunction of cortical progenitors and radial glia during early development, resulting in disruption of neuronal migration. Multiple steps of corticogenesis are likely to be disrupted in transmantle dysplasia, including progenitor proliferation (abnormal cell numbers), cell differentiation (presence of balloon cells, which are cells of indeterminate origin with variable expression of both glial and neuronal markers), and neuronal migration (dyslamination and neurons in the subcortical white matter). 2, 7 Future efforts can be aimed at performing detailed immunohistochemical and microstructural analysis of the focal area of abnormality to elucidate its detailed pathophysiology. Examining the periventricular regions may produce additional insight regarding this lesion and distinguish it from other types of cortical dysplasia.
Conclusions
Our study highlights the favorable postsurgical outcome in patients with the transmantle sign. In our series, all patients who underwent complete resection achieved seizure freedom, which is a greater rate than in other studies on FCD. Greater awareness of this unique entity with careful radiographic imaging will lead to improved detection of this pathology, which is particularly amenable to epilepsy surgery. 
